| Drug Name |
Zaleplon |
| Drug ID |
BADD_D02379 |
| Description |
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. |
| Indications and Usage |
For the treatment of short-term treatment of insomnia in adults. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N05CF03 |
| DrugBank ID |
DB00962
|
| KEGG ID |
D00530
|
| MeSH ID |
C085665
|
| PubChem ID |
5719
|
| TTD Drug ID |
D09DWL
|
| NDC Product Code |
50090-1564; 43063-783; 43063-505; 0054-0084; 71335-1054; 16436-0056; 63629-3405; 42043-210; 68788-7208; 71335-1466; 65862-215; 29300-132; 42043-211; 65862-214; 65862-197; 0054-0085; 71335-1387; 43063-912; 29300-131; 71335-0236; 57237-239; 51846-1026; 64330-054; 53296-0056; 57237-240; 45865-541 |
| Synonyms |
zaleplon | 3'-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide | N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide | L 846 | L-846 | Zelepion | Starnoc | SKP-1041 | CL 284,846 | CL-284846 | CL284,846 | CL 284846 | Sonata |
